期刊文献+

非酒精性脂肪性肝病与动脉粥样硬化关联性的研究进展 被引量:4

Research on advances of the relationship between nonalcoholic fatty liver disease and atherosclerosis
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是与遗传易感性和胰岛素抵抗(IR)密切相关的代谢应激性肝病,目前亦认为是代谢综合征(MS)的肝脏表现,常常与肥胖、2型糖尿病、高血压病、高脂血症以及MS等合并存在。近年来,NAFLD的患病率逐年增高,并且在2型糖尿病、肥胖患者中其患病率更高。动脉粥样硬化(AS)是心血管疾病(CVD)的基础,而目前研究发现NAFLD与CVD关系密切,NAFLD患者主要死亡原因是CVD和恶性肿瘤,NAFLD与AS关系亦密切,其机制目前仍不明确,可能涉及到胰岛素抵抗、血脂代谢紊乱、氧化应激、炎症反应、脂肪激素水平变化和肝功能等方面。本文就NAFLD和AS间的相关性及可能机制进行综述。 Nonalcoholic fatty liver disease (NAFLD), a metabolic stress-induced liver disease, is closely related to genetic susceptibility and insulin resistance (IR). It represents hepatic manifestation of metabolic syndrome (MS), and is associated with obesity, type 2 diabetes, hypertension, dyslipidemia, and metabolic syndrome. The prevalence of NAFLD increased year by year, and it is higher in the patients with type 2 diabetes and obesity. Atherosclerosis (AS) is the basic of cardiovascular disease (CVD), it is found that NAFLD was closely associated with CVD, and NAFLD was the cause of death in patients with CVD and malignant tumor. Also, there is a closely relationship between NAFLD and AS. The mechanism is not clear, and it may be related to insulin resistance, atherogenic dyslipidemia, oxidative stress, inflammation, the changes of fat hormone level and function in liver cell, etc. In this article, the relationship and possible mechanism between NAFLD and AS were reviewed.
出处 《中国肝脏病杂志(电子版)》 CAS 2015年第3期42-45,共4页 Chinese Journal of Liver Diseases:Electronic Version
基金 青岛市民生科技计划项目(14-2-3-17-nsh)
关键词 非酒精性脂肪性肝病 动脉粥样硬化 胰岛素抵抗 代谢综合征 心血管疾病 Nonalcoholic fatty liver disease Atherosclerosis Insulin resistance Metabolic syndrome Cardiovascular disease
  • 相关文献

参考文献30

  • 1Angulo P. Obesity and nonalcoholic fatty liver disease[J]. Nutr Rev,2007,65:S57-S63.
  • 2Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non- alcoholic fatty liver disease[J]. QJM,2010,103:71-83.
  • 3Souza MR, Diniz Mde F, Medeiros-Filho JE, et al. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease[J]. Arq Gastroenterol,2012,49:89-96.
  • 4Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology [J]. Gastroenterology,2012,142:1592-1609.
  • 5Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome[J]. Arterioscler Thromb Vasc Biol,2008,28:27-38.
  • 6Kim D, Kim WR, Kim HJ, et al. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States[J]. Hepatology,2013,57:1357-1365.
  • 7Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up[J]. Hepatology,2010,51:5951602.
  • 8Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease[J]. Hepatology,2005,42:473-480.
  • 9Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis[J]. Circulation,2007,115:459-467.
  • 10Fracanzani AL, Burdick L, Raselli S, et al. Carotid artery intima- media thickness in nonalcoholic fatty liver disease[J]. Am J Med,2008,121:72-78.

二级参考文献10

  • 1Raliq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver[J]. Clin Gastroenterol Hepatol, 2009, 7: 234- 238.
  • 2Grover-Piez F, Zavalza-G6mez AB. Endothelial dysfunction and cardiovascular risk factors[J]. Diabetes Res Clin Pratt, 2009, 84: 1-10.
  • 3The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Chin J Hepatol, 2010, 18: 163-166.
  • 4Rehabilitation Medicine Professional Committee of Vascular Chinese Association of Social Workers, International Society for Vascular Health China Branch, Peking University Shougang Hospital Vascular Medical Center. Chinese guideline for early vascular disease detection (2011 second report) [J]. Adv Cardiovasc Dis, 2011, 32:318-323.
  • 5Sookoian S, Castafio GO, Burguefio AL, et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease[J]. Atherosclerosis, 2010, 209: 585-591.
  • 6Degertekin B, Ozenirler S, Elbeg S, et al. The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis[J]. Dig Dis Sci, 2007, 52: 2622-2628.
  • 7Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis[J]. Circulation, 2007, 115: 459- 467.
  • 8Targher G, Bertolini L, Padovani R, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease[J]. Diabetes Care, 2006, 29: 1325- 1330.
  • 9Salvi P, Ruffini R, Agnoletti D, et al. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study[J]. J Hypcrtcns, 2010, 28: 1699-1707.
  • 10Miyano I, Nishinaga M, Takata J, et al. Association between brachial- ankle pulse wave velocity and 3-year mortality in community- dwelling older adults[J]. Hypertcns Res, 2010, 33: 678-682.

共引文献15

同被引文献41

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部